FGH 2020: COVID-19

FGH 2020: HIV/AIDS

Global health financing profile of spending on HIV/AIDS from 1990 to 2020.

FGH 2020: Malaria

Global health financing profile of spending on malaria from 1990 to 2020.

FGH 2020: Non-communicable diseases

Global health financing profile of spending on non-communicable diseases from 1990 to 2020.

FGH 2020: Other infectious diseases

Global health financing profile of spending on other infectious diseases from 1990 to 2020.

FGH 2020: Reproductive, maternal, newborn, and child health

Global health financing profile of spending on reproductive, maternal, newborn, and child health from 1990 to 2020.

FGH 2020: Tuberculosis

Global health financing profile of spending on tuberculosis from 1990 to 2020.

Spending for COVID-19 drove largest recorded increase in development assistance for health, but more is needed

A new study tracking global health spending finds that $13.7 billion in development assistance for health (DAH) went toward COVID-19 in 2020, contributing to a 35.7% increase in DAH spending compar...

Financing Global Health 2020: The Impact of COVID-19

This edition of IHME's annual Financing Global Health report, the 12th in the series, provides updated estimates of spending on health, development assistance...

Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050

We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development a...